Education

University of California, Berkeley, B.A., 01/2006, Molecular and Cell Biology
New York University School of Medicine, M.D., 01/2015, Medicine
New York University Sackler Institute, Ph.D., 01/2013, Developmental Genetics
University of California, San Francisco, Resident, 01/2018, Anatomic Pathology
University of California, San Francisco, Fellow, 01/2018, Surgical Pathology

Honors & Awards

  • 2002
    Regents' Scholarship, University of California, Berkeley
  • 2005
    Biology Fellows Program Semester Research Grant (Mentor: John Coates), University of California, Berkeley
  • 2007
    Summer Scholarship for Medical Students (Mentor: Joel Ernst), Infectious Diseases Society of America
  • 2008
    Award for Academic Excellence and Achievement, American Society of Clinical Pathology
  • 2011
    3rd place poster prize, 18th International C. elegans Meeting, Genetics Society of America
  • 2016
    Chief Resident, Department of Pathology, San Francisco VA Medical Center
  • 2016
    Pathologist in Training Travel Award, 92nd Annual AANP Meeting, American Association of Neuropathologists
  • 2017
    Chief Resident, Department of Pathology, San Francisco General Hospital
  • 2017
    Pathologist in Training Travel Award, USCAP Annual Meeting, United States and Canadian Academy of Pathology
  • 2017
    Visiting scholar. Genitourinary pathology. Mentor: Victor Reuter. 1 month., Memorial Sloan Kettering Cancer Center
  • 2018
    Visiting scholar. Genitourinary pathology. Mentor Jesse McKenney. 1 month., Cleveland Clinic

Selected Publications

  1. Salvatore L, Fakih M, Kuboki Y, Hong DS, Modest DP, Taieb J, Price TJ, Cremolini C, Majer IM, Rehn M, Chan E, Chen Z, Tran Q, Pietrantonio F. Matching-Adjusted Indirect Comparison of Sotorasib Plus Panitumumab Versus Trifluridine/Tipiracil Plus Bevacizumab in Chemorefractory Metastatic Colorectal Cancer. Clin Colorectal Cancer. 2026 Apr 23. View on PubMed
  2. Ding CC, Chan E, Lotan TL, Hang JF, Greenland NY, Stohr BA, Simko JP, Sirohi D. Renal Tumors Harboring FLCN Mutations: Case Series from Clinical Practice. Hum Pathol. 2026 Apr 16; 106122. View on PubMed
  3. Kuk M, Lowe A, Sangoi AR, Chan E. Digitally Assessed Nucleolar Size Compared to Traditional Pathologist WHO Grade Allocation in Clear Cell Renal Cell Carcinoma. Int J Surg Pathol. 2026 Mar 26; 10668969261429048. View on PubMed
  4. Mubeen A, Morrison CE, Pacheco R, Chan E, Acosta AM, Panizo A, Williamson SR, Nova-Camacho LM, Sangoi AR. Comprehensive immunohistochemical and molecular characterization of paratesticular clear cell papillary cystadenomas: A multi-institutional study of 14 cases. Ann Diagn Pathol. 2026 Aug; 83:152636. View on PubMed
  5. Endres NF, Do S, Mroue R, Terrett JA, Saabye M, Oh A, Hunsaker T, Chan E, Tran JC, Nguyen LK, Lian Q, Ma TP, Garner T, Gerosa L, Beresini M, Boudreau A, Bronner SM, Cyr P, Ishisoko N, Izrayelit Y, Jiang F, Kellar T, La H, Labadie S, Lardy M, Liu L, Liu W, Miller S, Rudolph J, Plise E, Sellers BD, Shao C, Wang W, Wang Y, Wei W, Wong S, Yu C, Yu K, Yuen PW, Zang R, Zhang C, Zhou Y, Zhu X, Quinn JG, Ye X, Kiefer JR, Mao J, Evangelista M, Merchant M, Landry ML, Malhotra S, Purkey HE. Discovery and Characterization of Divarasib (GDC-6036), a Potent Covalent Inhibitor of KRAS G12C. J Med Chem. 2026 Mar 12; 69(5):5147-5165. View on PubMed
  6. Mustapha R, Ganeshan B, Ellis S, Dolcetti L, Tharmakulasingam M, DeSouza K, Jiang X, Savage C, Lim S, Chan E, Thornton A, Hoy L, Endozo R, Shortman R, Walls D, Chen SH, Rowley M, Coolen ACC, Groves AM, Schnabel JA, Win T, Barber PR, Ng T. Fusing data from CT deep learning, CT radiomics and peripheral blood immune profiles to diagnose lung cancer in a cohort of patients experiencing symptoms. EBioMedicine. 2026 Mar; 125:106173. View on PubMed
  7. Wu DJ, Chan E. Histologic mimics of urothelial carcinoma. Semin Diagn Pathol. 2026 Mar; 43(2):150993. View on PubMed
  8. Shi WY, Liu KJ, Esfahani MS, Mach KE, Phillips NA, Almanza D, Bajpai RK, Schroers-Martin JG, Trabanino L, Lee TJ, La V, Rodriguez G, Holton G, Chen SB, Mullane P, Wu DJ, Nesselbush MC, Sugio T, Cheng JC, Jabara I, Hamilton EG, Alig SK, Liu CL, Peterson DJ, Prado K, Shkolyar E, Thong A, Shah JB, Gill H, Kunder CA, Chan E, Khaki AR, Skinner EC, Alizadeh AA, Liao JC, Diehn M. Field-effect-informed urine liquid biopsy for bladder cancer. Cell. 2026 Feb 19; 189(4):1024-1038.e9. View on PubMed
  9. Wu DJ, Pacheco R, Chan E, Lowe AC, Sangoi AR. Prostatic adenocarcinoma identified on transurethral resection of bladder tumor: A clinicopathologic series of a diagnostically relevant potential pitfall. Hum Pathol. 2026 May; 171:106059. View on PubMed
  10. Greenland NY, Cowan JE, Ding CC, Sirohi D, Cooperberg MR, Carroll PR, Simko JP, Stohr BA, Zhang L, Chan E. Correlation of unfavourable and favourable histology at radical prostatectomy with Decipher scores and freedom from biochemical recurrence. Histopathology. 2026 Feb; 88(3):605-614. View on PubMed
  11. McKenney JK, Brooks JD, Nguyen JK, Ding CKC, Newcomb LF, Myles JL, Alaghehbandan R, Przybycin CG, Chan E, Simko JP, Greenland NY, Schwen Z, Weight CJ, Cooperberg MR, Carroll PR. In reply to: 'Prostate cancer with favorable histology is not synonymous with prostate cancer indolence'. Histopathology. 2026 Jan; 88(2):549-550. View on PubMed
  12. Li S, Montini F, Song A, Willocq V, Chan E, Shamah R, Weiner M, Glanz BI, Weiner HL, Cox LM. Alterations of the nasal and oral microbiota in multiple sclerosis. EBioMedicine. 2025 Nov; 121:105959. View on PubMed
  13. Lu ER, Cheng PW, Lo SSM, Siu CWY, Fu ECH, Yau JPW, Lee ACW, Wong KC, Kan EYL, Lau SSN, Ho WWS, Cheng KKF, Chan EKY, Ng HK, Kan ANC, Chan GCF, Ku DTL, Shing MMK, Liu APY, Siu DYW. Clinical Utility of Amino Acid PET-MRI in Children with CNS Neoplasms: A Territory-Wide Study from Hong Kong. Cancers (Basel). 2025 Oct 04; 17(19). View on PubMed
  14. Papanicolau-Sengos A, Singh O, Park K, Snuderl M, Tretiakova M, Merino M, Stohr B, Simko J, Deng FM, Chan E, Wu J, Barreto J, Gupta R, Park B, Turakulov R, Abdullaev Z, Solomon DA, Aldape K. DNA Methylation-Based Classification of Kidney Neoplasms. Mod Pathol. 2025 Nov; 38(11):100884. View on PubMed
  15. Chang K, Delavan HM, Yip E, Kasap C, Zhu J, Lodha R, Liao SY, Berman SC, Carretero-Gonzalez A, Basar M, Gokturk Ozcan G, Teo MY, Solit DB, Rosenberg JE, Al-Ahmadie H, Ding CCK, Chan E, Steri V, Porten SP, Koshkin VS, Friedlander TW, Feng FY, Lee JK, Wiita AP, Chu CE, Chou J. Modulating the PPARγ pathway upregulates NECTIN4 and enhances chimeric antigen receptor (CAR) T cell therapy in bladder cancer. Nat Commun. 2025 Sep 10; 16(1):8215. View on PubMed
  16. Sirohi D, Cornelia Ding CK, Stohr BA, Balassanian R, Vohra P, Aggarwal R, Chan E, Greenland NY. The utility of next-generation sequencing in metastatic prostate cancer FNA biopsies. Cancer Cytopathol. 2025 09; 133(9):e70038. View on PubMed
  17. Rizkalla CN, Tretiakova M, Suarez CJ, Williamson SR, Al-Obaidy KI, Acosta AM, Idrees MT, Chan E, Potterveld S, Sangoi AR. Urothelial carcinoma with osteoclast-like giant cells: An expanded immunohistochemical and molecular profile. Am J Clin Pathol. 2025 Aug 26; 164(2):257-264. View on PubMed
  18. Rizkalla CN, Tretiakova M, Williamson SR, Akgul M, Al-Obaidy KI, Acosta AM, Idrees MT, Chan E, Sangoi AR. Overlapping Morphologic and Immunophenotypic Features of Plasmacytoid Urothelial Carcinoma and Urothelial Carcinoma With Osteoclast-Like Giant Cells. Int J Surg Pathol. 2026 Apr; 34(2):309-314. View on PubMed
  19. Modest DP, Fakih M, Salvatore L, Esaki T, Lopez-Bravo DP, Taieb J, Karamouzis M, Ruiz-Garcia E, Kim TW, Kuboki Y, Meriggi F, Cunningham D, Yeh KH, Cremolini C, Tran Q, Chan E, Chao J, Majer IM, Pietrantonio F. Health-related quality of life in patients with KRASG12C-mutated chemorefractory metastatic colorectal cancer treated with sotorasib plus panitumumab or standard of care (CodeBreaK 300): results from a phase 3, randomised clinical trial. Lancet Oncol. 2025 Sep; 26(9):1240-1251. View on PubMed
  20. Gao H, Ren D, Giannico GA, Akgul M, Khani F, Galea LA, Al-Obaidy KI, Falzarano SM, Wobker SE, Barry-Holson KQ, Chan E, McHenry AJ, Sangoi AR. Do urinary bladder smooth muscle neoplasms show morphologic and immunophenotypic features of their uterine fumarate hydratase-deficient counterparts? Ann Diagn Pathol. 2025 Dec; 79:152536. View on PubMed

Go to UCSF Profiles, powered by CTSI